|Articles|November 27, 2021

First of a New Class of Drugs to Treat Early-Stage Triple-Negative Breast Cancer Approved

A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer.

Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with limited treatment options. A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer. Read more in our XRAY review. #helpnothype #BehindtheCancerHeadlines

https://www.facingourrisk.org/XRAY/pembrolizumab-for-triple-negative-breast-cancer?utm_source=CURE&utm_medium=website&utm_campaign=organic_social_website

Stay up to date on cancer updates, research and education

Subscribe Now!

First of a New Class of Drugs to Treat Early-Stage Triple-Negative Breast Cancer Approved

Newsletter

Trending on CURE

FDA Updates Safety Warnings for Common Chemotherapy Drugs

FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma

Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma

Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us

New Combination Treatment Approach Studied in Pancreatic Cancer